These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34907003)

  • 1. Hyperbaric oxygen as an adjuvant treatment for patients with COVID-19 severe hypoxaemia: a randomised controlled trial.
    Cannellotto M; Duarte M; Keller G; Larrea R; Cunto E; Chediack V; Mansur M; Brito DM; García E; Di Salvo HE; Verdini F; Domínguez C; Jorda-Vargas L; Roberti J; Di Girolamo G; Estrada E
    Emerg Med J; 2022 Feb; 39(2):88-93. PubMed ID: 34907003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperbaric oxygen therapy may be effective to improve hypoxemia in patients with severe COVID-2019 pneumonia: two case reports.
    Guo D; Pan S; Wang M; Guo Y
    Undersea Hyperb Med; 2020; 47(2):181-187. PubMed ID: 32574433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial.
    Crimi C; Noto A; Madotto F; Ippolito M; Nolasco S; Campisi R; De Vuono S; Fiorentino G; Pantazopoulos I; Chalkias A; Libra A; Mattei A; Scala R; Clini EM; Ergan B; Lujan M; Winck JC; Giarratano A; Carlucci A; Gregoretti C; Groff P; Cortegiani A;
    Thorax; 2023 Apr; 78(4):354-361. PubMed ID: 35580898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperbaric oxygen for COVID-19 patients with severe hypoxia prior to vaccine availability.
    Jansen D; Dickstein DR; Erazo K; Stacom E; Lee DC; Wainwright SK
    Undersea Hyperb Med; 2022; 49(3):295-305. PubMed ID: 36001562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five sessions of hyperbaric oxygen for critically ill patients with COVID-19-induced ARDS: A randomised, open label, phase II trial.
    Kjellberg A; Douglas J; Pawlik MT; Hassler A; Al-Ezerjawi S; Boström E; Abdel-Halim L; Liwenborg L; Jonasdottir-Njåstad AD; Kowalski J; Catrina SB; Rodriguez-Wallberg KA; Lindholm P
    Respir Med; 2024 Oct; 232():107744. PubMed ID: 39059726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive ventilation versus high-flow nasal cannula oxygen therapy with apnoeic oxygenation for preoxygenation before intubation of patients with acute hypoxaemic respiratory failure: a randomised, multicentre, open-label trial.
    Frat JP; Ricard JD; Quenot JP; Pichon N; Demoule A; Forel JM; Mira JP; Coudroy R; Berquier G; Voisin B; Colin G; Pons B; Danin PE; Devaquet J; Prat G; Clere-Jehl R; Petitpas F; Vivier E; Razazi K; Nay MA; Souday V; Dellamonica J; Argaud L; Ehrmann S; Gibelin A; Girault C; Andreu P; Vignon P; Dangers L; Ragot S; Thille AW; ;
    Lancet Respir Med; 2019 Apr; 7(4):303-312. PubMed ID: 30898520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress: treated cases versus propensity-matched controls.
    Gorenstein SA; Castellano ML; Slone ES; Gillette B; Liu H; Alsamarraie C; Jacobson AM; Wall SP; Adhikari S; Swartz JL; McMullen JJS; Osorio M; Koziatek CA; Lee DC
    Undersea Hyperb Med; 2020; 47(3):405-413. PubMed ID: 32931666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UHMS Position Statement: Hyperbaric Oxygen (HBO2) for COVID-19 Patients.
    Undersea Hyperb Med; 2020; 47(2):297-298. PubMed ID: 32574446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bubble continuous positive airway pressure for children with severe pneumonia and hypoxaemia in Bangladesh: an open, randomised controlled trial.
    Chisti MJ; Salam MA; Smith JH; Ahmed T; Pietroni MA; Shahunja KM; Shahid AS; Faruque AS; Ashraf H; Bardhan PK; Sharifuzzaman ; Graham SM; Duke T
    Lancet; 2015 Sep; 386(9998):1057-65. PubMed ID: 26296950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised controlled trial of oxygen therapy and high-flow nasal therapy in African children with pneumonia.
    Maitland K; Kiguli S; Olupot-Olupot P; Hamaluba M; Thomas K; Alaroker F; Opoka RO; Tagoola A; Bandika V; Mpoya A; Mnjella H; Nabawanuka E; Okiror W; Nakuya M; Aromut D; Engoru C; Oguda E; Williams TN; Fraser JF; Harrison DA; Rowan K;
    Intensive Care Med; 2021 May; 47(5):566-576. PubMed ID: 33954839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial".
    Tornero C; Vallejo R; Cedeño D; Orduña J; Pastor E; Belaouchi M; Escamilla B; Laredo M; Del Mar Garzando M
    Trials; 2020 Jun; 21(1):576. PubMed ID: 32586395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperbaric oxygen therapy for long COVID (HOT-LoCO), an interim safety report from a randomised controlled trial.
    Kjellberg A; Hassler A; Boström E; El Gharbi S; Al-Ezerjawi S; Kowalski J; Rodriguez-Wallberg KA; Bruchfeld J; Ståhlberg M; Nygren-Bonnier M; Runold M; Lindholm P
    BMC Infect Dis; 2023 Jan; 23(1):33. PubMed ID: 36670365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperbaric oxygen as a treatment for COVID-19 infection?
    Moon RE; Weaver LK
    Undersea Hyperb Med; 2020; 47(2):177-179. PubMed ID: 32574432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologic and biochemical rationale for treating COVID-19 patients with hyperbaric oxygen.
    Feldmeier JJ; Kirby JP; Buckey JC; Denham DW; Evangelista JS; Gelly HB; Harlan NP; Mirza ZK; Ray KL; Robins M; Savaser DJ; Wainwright S; Bird N; Huang ET; Moon RE; Thom SR; Weaver LK
    Undersea Hyperb Med; 2021; 48(1):1-12. PubMed ID: 33648028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.
    Estenssoro E; Loudet CI; Ríos FG; Kanoore Edul VS; Plotnikow G; Andrian M; Romero I; Piezny D; Bezzi M; Mandich V; Groer C; Torres S; Orlandi C; Rubatto Birri PN; Valenti MF; Cunto E; Sáenz MG; Tiribelli N; Aphalo V; Reina R; Dubin A;
    Lancet Respir Med; 2021 Sep; 9(9):989-998. PubMed ID: 34224674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-flow nasal oxygenation or standard oxygenation for gastrointestinal endoscopy with sedation in patients at risk of hypoxaemia: a multicentre randomised controlled trial (ODEPHI trial).
    Nay MA; Fromont L; Eugene A; Marcueyz JL; Mfam WS; Baert O; Remerand F; Ravry C; Auvet A; Boulain T
    Br J Anaesth; 2021 Jul; 127(1):133-142. PubMed ID: 33933271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prone positioning of patients with moderate hypoxaemia due to covid-19: multicentre pragmatic randomised trial (COVID-PRONE).
    Fralick M; Colacci M; Munshi L; Venus K; Fidler L; Hussein H; Britto K; Fowler R; da Costa BR; Dhalla I; Dunbar-Yaffe R; Branfield Day L; MacMillan TE; Zipursky J; Carpenter T; Tang T; Cooke A; Hensel R; Bregger M; Gordon A; Worndl E; Go S; Mandelzweig K; Castellucci LA; Tamming D; Razak F; Verma AA;
    BMJ; 2022 Mar; 376():e068585. PubMed ID: 35321918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19.
    Kjellberg A; Douglas J; Pawlik MT; Kraus M; Oscarsson N; Zheng X; Bergman P; Frånberg O; Kowalski JH; Nyren SP; Silvanius M; Skold M; Catrina SB; Rodriguez-Wallberg KA; Lindholm P
    BMJ Open; 2021 Jul; 11(7):e046738. PubMed ID: 34226219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of feasibility phase of adaptive version of locally made bubble continuous positive airway pressure oxygen therapy for the treatment of COVID-19 positive and negative adults with severe pneumonia and hypoxaemia.
    Chisti MJ; Rahman AE; Hasan T; Ahmed T; El Arifeen S; Clemens JD; Rahman ASMMH; Uddin MF; Amin MR; Miah MT; Islam MK; Sharif M; Shahid ASMSB; Ahmed A; Banik G; Rashid M; Ahmed MK; Shahrin L; Afroze F; Sarmin M; Nuzhat S; Sarkar S; Islam J; Islam MS; Norrie J; Campbell H; Nair H; Cunningham S
    J Glob Health; 2023 Nov; 13():06046. PubMed ID: 37997786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial.
    Aman J; Duijvelaar E; Botros L; Kianzad A; Schippers JR; Smeele PJ; Azhang S; Bartelink IH; Bayoumy AA; Bet PM; Boersma W; Bonta PI; Boomars KAT; Bos LDJ; van Bragt JJMH; Braunstahl GJ; Celant LR; Eger KAB; Geelhoed JJM; van Glabbeek YLE; Grotjohan HP; Hagens LA; Happe CM; Hazes BD; Heunks LMA; van den Heuvel M; Hoefsloot W; Hoek RJA; Hoekstra R; Hofstee HMA; Juffermans NP; Kemper EM; Kos R; Kunst PWA; Lammers A; van der Lee I; van der Lee EL; Maitland-van der Zee AH; Mau Asam PFM; Mieras A; Muller M; Neefjes ECW; Nossent EJ; Oswald LMA; Overbeek MJ; Pamplona CC; Paternotte N; Pronk N; de Raaf MA; van Raaij BFM; Reijrink M; Schultz MJ; Serpa Neto A; Slob EMA; Smeenk FWJM; Smit MR; Smits AJ; Stalenhoef JE; Tuinman PR; Vanhove ALEM; Wessels JN; van Wezenbeek JCC; Vonk Noordegraaf A; de Man FS; Bogaard HJ
    Lancet Respir Med; 2021 Sep; 9(9):957-968. PubMed ID: 34147142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.